Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Core EBITDA Growth

    Back to All Ratios
PIRAMAL PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 15.1660.74-30.36-23.03-

What is the latest Core EBITDA Growth ratio of PIRAMAL PHARMA ?

The latest Core EBITDA Growth ratio of PIRAMAL PHARMA is 15.16 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202515.16
Mar202460.74
Mar2023-30.36
Mar2022-23.03
Mar2021-

How is Core EBITDA Growth of PIRAMAL PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 15.16
-75.04
Mar2024 60.74
Positive
Mar2023 -30.36
Negative
Mar2022 -23.03
0
Mar2021 0 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Core EBITDA Growth ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹21,240.6 Cr -2.7% 11.9% -24.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹436,859.0 Cr 4.2% 5.3% 1.1% Stock Analytics
DIVIS LABORATORIES ₹176,618.0 Cr 3.4% 12.6% 8.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,718.0 Cr 2.2% 4.1% 28% Stock Analytics
CIPLA ₹107,722.0 Cr 2% 11.5% -13.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,081.0 Cr -6.2% 5.1% 9.5% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-2.7%

11.9%

-24.4%

SENSEX

-0.4%

7.1%

-4%


You may also like the below Video Courses